Oss, Netherlands

Wouter De Graaff

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 108(Granted Patents)


Location History:

  • Oss, FR (2015)
  • Oss, NL (2012 - 2016)

Company Filing History:


Years Active: 2012-2016

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Wouter De Graaff

Introduction: Wouter De Graaff is a prominent inventor based in Oss, Netherlands, holding an impressive portfolio of 11 patents. His innovative work primarily focuses on drug delivery systems, influencing both human and veterinary medicine. With a strong educational background and extensive industry experience, De Graaff has made significant strides in the field of therapeutic delivery.

Latest Patents: Among his latest inventions, Wouter De Graaff has developed a Macrocyclic Lactone Drug Delivery System, which allows for the controlled release of macrocyclic lactones with a desirable zero-order release profile. This advanced system utilizes thermoplastic polymers, specifically polyethylene vinyl acetate copolymers (EVA), and features a solid non-porous reservoir to keep the drug concentrated above saturation levels. The system is designed in the shape of a rod, ensuring that the drug is effectively released while maintaining integrity.

Another notable invention is his veterinary drug delivery system aimed at promoting the growth of animals. This innovative device simultaneously releases multiple active substances in a consistent ratio over an extended period. The versatility of this system allows it to take various forms, such as an implant or an intravaginal device, including helical coils, springs, or rings.

Career Highlights: Throughout his career, Wouter De Graaff has collaborated with leading companies in pharmaceutical and veterinary sectors, notably Merck Sharp & Dohme B.V. and Intervet Inc. His work has pushed the boundaries of conventional drug delivery methods, paving the way for more effective therapies.

Collaborations: De Graaff's innovative journey has led him to collaborate with esteemed colleagues like Raymond Zeeman and Harm Veenstra. These partnerships have been crucial in refining his inventions and enhancing their practical applications.

Conclusion: Wouter De Graaff exemplifies the spirit of innovation in the pharmaceutical industry. With a commitment to developing advanced drug delivery systems, his contributions are poised to have a lasting impact on both human and veterinary medicine. As he continues to push the envelope of technology and therapeutic delivery, his work stands as a testament to the importance of innovation in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…